COR is down 0.30% today. Volume is 993.5K vs a 30-day average of 1.25M (0.80x).
Cencora, Inc. is scheduled to report earnings Wed, Nov 4, 2026 · after close. Analysts expect EPS of $4.62 on revenue of about $88.88B. Stocks often move sharply on earnings day.
Cencora (COR) has moved to take control of American Oncology Network (OTCPK:AONC) by signing a deal to acquire the remaining 96% it does not own for an enterprise value of $2.4b. …
Baird analyst David Rodgers maintains Cencora (NYSE:COR) with a Outperform and raises the price target from $373 to $375.
CONSHOHOCKEN, Pa. & FORT MYERS, Fla., October 21, 2026--Cencora, Inc. (NYSE: COR) today announced it has signed a definitive agreement to acquire American Oncology Network, Inc. (…
Cencora (NYSE:COR) has outperformed the market over the past 5 years by 11.54% on an annualized basis producing an average annual return of 22.6%. Currently, Cencora has a market …
Cencora, Inc. (NYSE: COR) today announced it has signed a definitive agreement to acquire American Oncology Network, Inc. ("AON") (OTCQX:AONC), a physician-led network of …